BMYMP.PFD (Bristol-Myers Squibb Co) Tax Provision : $-367.00 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Bristol-Myers Squibb Co Tax Provision?

Bristol-Myers Squibb Co's tax provision for the three months ended in Sep. 2024 was $-461.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was $-367.00 Mil.

Bristol-Myers Squibb Co Tax Provision Historical Data

The historical data trend for Bristol-Myers Squibb Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Tax Provision Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-1,515.00

-2,124.00

-1,084.00

-1,368.00

-400.00

Bristol-Myers Squibb Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-203.00	88.00	-392.00	398.00	-461.00

Bristol-Myers Squibb Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-367.00 Mil.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (OTCPK:BMYMP.PFD) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.